MYND Life Sciences Inc (MYND)

[namah sivaya]

MYND VOTE 7/9 on Emmaus Life Sciences reverse merger!

found this article was posted from 2017 entitled, "Mystery biotech Emmaus grabs groundbreaking FDA panel backing for sickle cell drug — after quietly scrapping $225M deal"

here is the link;
https://endpts.com/mystery-biotech-emmaus-grabs-a-big-win-as-fda-experts-endorse-sickle-cell-drug-right-after-scrapping-a-225m-deal/

it seems Emmaus scrapped the deal when it was apparent the FDA was going to approve Endari, the Sickle Cell Disease drug. probably because Emmaus mgmt knew they were worth more. so what's Emmaus worth now?

according to this Sickle Cell research article the Sickle Cell market size is $2.1B, growing to $4.5B by 2025. the article also list the key players. Emmaus is first on the list;

The key players covered in this study:
Emmaus Medical
Addmedica
Gamida Cell
GlycoMimetics
Pfizer
Novartis
Global Blood Therapeutics
Micelle BioPharma
Bluebird Bio
Prolong Pharmaceuticals
Modus Therapeutics
Sangamo Biosciences
Bioverativ
Imara
Ironwood Pharmaceuticals

here is a link to the article

https://t.co/DOPy4WBRtS

considering we are not even talking about the Telepsychiatry and PEER 4.0 AI device here, MYND's market cap seems to be extremely cheap.